|[February 27, 2013]
Acurian, the Patient Enrollment and Retention Specialist, Achieves 15-Year Milestone
HORSHAM, Pa. --(Business Wire)--
Acurian, Inc., a leading, full-service provider of global patient
enrollment and retention solutions, announced today it has reached its 15th
year in business. What started as a data/information company in the
dotcom era has evolved into a company that is now the recognized leader
in its industry.
"Acurian's breadth and depth of experience is complimented by being a
true pioneer and thought-leader," said Rick Malcolm, Acurian's CEO.
"Over the last 15 years, Acurian has grown into the company more
clinical trial sponsors turn to with their patient enrollment and
engagement challenges. Our industry innovations have driven much of this
success," he continued.
According to Malcolm, some of the company's key innovations include:
Built first clnical trial registration website
Developed the first centralized technology platform for pre-screening
potential trial participants, and tracking enrollment and retention
metrics for patients and sites
Built the first and largest database of people who have opted-in to
receive information about clinical trials (currently over 70 million)
First to offer trial sponsors performance-based pricing where
customers pay based on Acurian's ability to reach specific milestones,
including patient randomization
First to develop social media applications designed to raise clinical
Acurian plans to promote its 15th Anniversary via various
channels including the company's impending new website, trade shows,
conferences, and collateral materials.
Acurian is a leading full-service provider of clinical trial patient
enrollment and retention solutions for the life sciences industry. The
company increases the enrollment performance of investigator sites
worldwide by identifying, contacting, prescreening, and referring people
who live in the local community but are unknown to a research site. As a
result, trial sponsors complete enrollment without incurring the
unexpected expense of adding sites, time, or CRO change orders.
Acurian's investors include Euclid SR Partners, ProQuest Investments, JP
Morgan Partners, Flatiron Partners, CDP Capital Technology Ventures, and
Merck Capital Ventures.
[ Back To Technology News's Homepage ]